All patients, doctors and pharmacists involved with the prescription acne drug Accutane and three generic versions are to be placed on a national registry by the FDA as a way of trying to prevent women from becoming pregnant while taking the drug. The intent is to make sure women are monitored if they become pregnant because Roche's drug has been found to cause birth defects related to the face and central nervous system.

Related Summaries